This invention relates to methods to identify specific inhibitors of the purine nucleotide synthesis enzyme, IMP dehydrogenase (IMPDH). IMPDH is an essential enzyme found in all free-living organisms from humans to bacteria and is an important therapeutic target. The invention allows the identification of specific inhibitors of any IMPDH enzyme which can be expressed in a functional form in a recombinant host cell. A variety of eukaryotic or prokaryotic host systems commonly used for the expression of recombinant proteins are suitable for the practice of the invention. The methods are amenable to high throughput systems for the screening of inhibitors generated by combinatorial chemistry or other methods such as antisense molecule productio...
Helicobacter pylori�(H. pylori), the major cause of several gastric disorders has been recognied as ...
SummaryThe protozoan parasite Cryptosporidium parvum is a major cause of gastrointestinal disease; n...
Thiazole-4-carboxamide adenine dinucleotide (TAD) analogues T-2'-MeAD (1) and T-3'-MeAD (2) containi...
Inosine 5´-monophosphate dehydrogenase (IMPDH) is a vital enzyme involved in the de-novo synthesis o...
Inosine 5′-monophosphate dehydrogenase (IMPDH) is an essential enzyme for the production of guanine ...
(IMPDH) catalyzes the rate-limiting step in de novo guanine nucleotide synthesis and is implicated i...
Inosine monophosphate dehydrogenase (IMPDH), an NAD-dependent enzyme that controls de novo synthesis...
Inosine monophosphate dehydrogenase (IMPDH), an NAD-dependent enzyme that controls de novo synthesis...
Inosine 5′-monophosphate dehydrogenase (IMPDH, EC 1.1.1.205) catalyzes a crucial step in guanine nuc...
Guanine nucleotides are essential for many cellular functions. Therefore inosine monophosphate dehyd...
Inosine Monophosphate Dehydrogenase (IMPDH) is a well known therapeutic target for new drug developm...
Synthesis of novel inhibitors of human IMP dehydrogenase is described. These inhibitors are isosteri...
Human type II inosine 5{prime}-monophosphate dehydrogenase (IMPDH, EC 1.1.1.205) is the rate-limitin...
International audienceProper nucleosides availability is crucial for the proliferation of living ent...
Inosine monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme in the de novo synthesis of guan...
Helicobacter pylori�(H. pylori), the major cause of several gastric disorders has been recognied as ...
SummaryThe protozoan parasite Cryptosporidium parvum is a major cause of gastrointestinal disease; n...
Thiazole-4-carboxamide adenine dinucleotide (TAD) analogues T-2'-MeAD (1) and T-3'-MeAD (2) containi...
Inosine 5´-monophosphate dehydrogenase (IMPDH) is a vital enzyme involved in the de-novo synthesis o...
Inosine 5′-monophosphate dehydrogenase (IMPDH) is an essential enzyme for the production of guanine ...
(IMPDH) catalyzes the rate-limiting step in de novo guanine nucleotide synthesis and is implicated i...
Inosine monophosphate dehydrogenase (IMPDH), an NAD-dependent enzyme that controls de novo synthesis...
Inosine monophosphate dehydrogenase (IMPDH), an NAD-dependent enzyme that controls de novo synthesis...
Inosine 5′-monophosphate dehydrogenase (IMPDH, EC 1.1.1.205) catalyzes a crucial step in guanine nuc...
Guanine nucleotides are essential for many cellular functions. Therefore inosine monophosphate dehyd...
Inosine Monophosphate Dehydrogenase (IMPDH) is a well known therapeutic target for new drug developm...
Synthesis of novel inhibitors of human IMP dehydrogenase is described. These inhibitors are isosteri...
Human type II inosine 5{prime}-monophosphate dehydrogenase (IMPDH, EC 1.1.1.205) is the rate-limitin...
International audienceProper nucleosides availability is crucial for the proliferation of living ent...
Inosine monophosphate dehydrogenase (IMPDH), a rate-limiting enzyme in the de novo synthesis of guan...
Helicobacter pylori�(H. pylori), the major cause of several gastric disorders has been recognied as ...
SummaryThe protozoan parasite Cryptosporidium parvum is a major cause of gastrointestinal disease; n...
Thiazole-4-carboxamide adenine dinucleotide (TAD) analogues T-2'-MeAD (1) and T-3'-MeAD (2) containi...